[ Skip to main content ]

The New Zealand Drug Foundation today made its submission to the Health Select Committee on the Psychoactive Substances Bill saying it was a good bill but there are improvements to be made.

The bill, which clarifies the law around substances like synthetic cannabis and party pills, is a world first attempt to regulate the market around legal highs, Drug Foundation Executive Director Ross Bell said.

"Given concern around the harm these substances are causing in our communities, the bill needs to explicitly state the legislation is about harm-reduction and health," Mr Bell said.

"Harm reduction and health need to be at the forefront of policymakers’ and politicians’ minds when making decisions about the design and delivery of this bill.

"Enshrining this purpose in the primary legislation future proofs the bill and ensures this overarching goal is given precedence over competing priorities."

Mr Bell said expanding the collection of health information about these substances and making that available to the public was also essential.

"New Zealand has been notoriously slack in collecting and sharing good data on the effects these substances are having and we need to become much more proactive in that respect.

"As well as maintaining a register of approved products, data on the health and social impacts of all approved and unapproved products should be kept and made available so the public can make informed decisions."

The Drug Foundation also recommended that all penalties related to the possession of substances be removed. This includes carrying a product or suspicion of carrying a product.

"Penalties serve no useful purpose in the bill and risk expanding criminal sanctions against young people in particular."

Mr Bell said that despite this, New Zealand Drug Foundation strongly supports this bill.

"While other countries are still blindly banning drug after drug, the Psychoactive Substances Bill puts New Zealand ahead of the industry’s game. It is a pragmatic and innovative attempt to address a complex problem.

"We hope the committee act on our recommendations and those of other community groups to strengthen the bill and increase its ability to promote health and reduce harm."

Share:

Related See more

Opinion: What we know about drugs in NZ in 2020

Kali Mercier sets out what we know in 2020, and outlines how the need to collect accurate information has never been greater.

MoS nov 2019 thumbnailjack in canada

Lessons from the Canadian cannabis legalisation

Indigenous Canadians have been dissatisfied with the way cannabis legalisation has failed to work for them.

MoS nov 2019 thumbnail rally

Unify rally to end our drug war

A glimpse of what happened at Auckland Town Hall at the Unify Rally on Monday 16 September. Photographer Katrina Elton was on hand to captu...

MoS nov 2019 thumbnail prescriptions image

Unawareness and cost block cannabis prescriptions

Although medicinal cannabis was made legal in New Zealand, the medical profession has been slow to widely adopt the new option. Russell Brow...

e substance newsletter promotional thumbnail

Sign-up for email updates

The latest New Zealand drug news, analysis and updates from us.

Subscribe now

Did You Know resources thumbnail

Did You Know

Conversation tools for parents, caregivers and youth workers to help your young person make safer decisions about drugs.

Learn more

Back to top